ArticleVirchows Archiv : an international journal of pathology2023
The devil is in the details: a small-lesion sensitive weakly supervised learning framework for prostate cancer detection and grading.
Article in Virchows Archiv : an international journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Patch-Wise Approach with Vision Transformer for Detecting Implant Failure in Spinal Radiography.Journal of imaging informatics in medicine · 2026Article
- Benchmarking foundation models as feature extractors for weakly supervised computational pathology.Nature biomedical engineering · 2026Article
- Current Applications and Future Directions of Artificial Intelligence in Prostate Cancer Diagnosis: A Narrative Review.Current oncology (Toronto, Ont.) · 2026Review
- Automating Prostate Cancer Grading: A Novel Deep Learning Framework for Automatic Prostate Cancer Grade Assessment using Classification and Segmentation.Journal of imaging informatics in medicine · 2025Article
- Longitudinal outcome prediction of prostate cancer patients on active surveillance using multiple instance learning.Journal of medical imaging (Bellingham, Wash.) · 2025Article
- Fine art image classification and design methods integrating lightweight deep learning.Scientific reports · 2025Article
- The Role of Artificial Intelligence in the Evaluation of Prostate Pathology.Pathology international · 2025Review
- Harnessing artificial intelligence for prostate cancer management.Cell reports. Medicine · 2024Review
- SAMPLER: unsupervised representations for rapid analysis of whole slide tissue images.EBioMedicine · 2024Article
- One label is all you need: Interpretable AI-enhanced histopathology for oncology.Seminars in cancer biology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer (PCa) is a significant health concern in aging males, and the diagnosis depends primarily on histopathological assessments to determine tumor size and Gleason score. This process is highly time-consuming, subjective, and relies on the extensive experience of the pathologists. Deep learning based artificial intelligence shows an ability to match pathologists on many prostate cancer diagnostic scenarios. However, it is easy to make mistakes on some hard cases with small tumor areas considering the extensively high-resolution of whole slide images (WSIs). The absence of fine-grained and large-scale annotations of such small tumor lesions makes this problem more challenging. Existing methods usually perform uniform cropping of the foreground of WSI and then use convolutional neural networks as the backbone network to predict the classification results. However, cropping can damage the structure of tiny tumors, which affects classification accuracy. To solve this problem, we propose an Intensive-Sampling Multiple Instance Learning Framework (ISMIL), which focuses on tumor regions and improves the recognition of small tumor regions by intensively sampling the crucial regions. Experiments of prostate cancer detection show that our method achieves an area under the receiver operating characteristic curve (AUC) of 0.987 on the PANDA sets, which improves recall by at least 33% with higher specificity over the current primary methods for hard cases. The ISMIL also demonstrates comparable abilities to human experts on the prostate cancer grading task. Moreover, ISMIL has shown good robustness in independent cohorts, which makes it a potential tool to improve the diagnostic efficiency of pathologists.
Indexed as
Identifiers
36823229What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.